IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release: Audited Financial Results for the quarter and half year ended 30th September 202308-11-2023
08-11-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Audited Financial Results For The Quarter And Half Year Ended 30Th September 2023
Please find attached herewith Audited Financial Results for the quarter and half year ended 30th September 202308-11-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting - Audited Financial Results For The Quarter And Half Year Ended 30Th September 2023
Dear Sir, Pursuant to Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 8th November 2023 has inter alia considered and approved the Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September 2023. The Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September 2023 along with Auditors Report thereon is enclosed herewith. We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2023 is an Unmodified Report. The meeting of Board of Directors commenced at 12:30 PM and concluded at 3:50 PM. The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com.08-11-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ,this is to inform you that the Company is organizing an analyst /investor conference call on Thursday, 9th November 2023 at 4:00 PM (IST) to discuss the financial performance of the Company for the Q2 & H1 FY24.06-11-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates31-10-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Intimation for Notice Of The Board Meeting
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve the Audited Financial Results of the Company for the Quarter and half year ended 30th September 202330-10-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of letter of confirmation dated 10/10/2023 to the shareholders in lieu of lost share certificates11-10-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations11-10-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Plant visit for Analysts04-10-2023
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates04-10-2023